Evidence map›Paper›PMID 37028843›Full record

ReviewRheumatic diseases clinics of North America2023

Preventative Care in Scleroderma: What Is the Best Approach to Vaccination?

Leonardo Martin Calderon, Janet E Pope, Ami A Shah, Robyn T Domsic

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Rheumatic diseases clinics of North America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Leonardo Martin CalderonDepartment of Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
Janet E PopeDepartment of Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada; Division of Rheumatology, St. Joseph's Health Care, London, Ontario, Canada.
Ami A ShahDivision of Rheumatology, Johns Hopkins University School of Medicine, Johns Hopkins Scleroderma Center, Baltimore, MD, USA.
Robyn T DomsicDivision of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, 3500 Terrace Street, Pittsburgh, PA 15261, USA. Electronic address: rtd4@pitt.edu.
Johns Hopkins University · USSt Joseph's Health Care · CAUniversity of Pittsburgh · USWestern University · CA

Funding

Harnessing multivariate patient- and population-level disease trajectories to predict major clinical events in sclerodermaK24AR080217 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI Ami Aalok Shah · 2022 to 2026
$847k
Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic DiseaseR01AR080356 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ASCHERMAN, DANA P, DOMSIC, ROBYN THERESE · 2022 to 2024
$655k
NIAMS NIH HHS K24 AR080217NIAMS NIH HHS R01 AR080356
6 · The paper itself

Abstract

Systemic sclerosis (SSc) is a rare multisystem autoimmune disease characterized by fibrosis, vasculopathy, and autoimmunity. There are multiple complications inherent to SSc and its management. One of these complications is increased infection risk, which can lead to decreased quality of life and increased morbidity and mortality. Patients with SSc have lower vaccination rates and decreased vaccine seroconversion secondary to immunosuppressive medications compared with the general population. The purpose of this review is to provide clinicians with an approach to vaccinations in SSc.

Indexed as

Quality of LifeScleroderma, SystemicAutoimmunityFibrosisHumansVaccinationPreventative medicinePreventionSARS-CoV-2SclerodermaSystemic sclerosisVaccinationVaccines

Identifiers

PMID37028843
PMCPMC10875978
OpenAlexW4362674617

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.